Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Y. Bastion"'
Publikováno v:
Hematological Oncology. 9:225-233
A prospective phase II study was performed to evaluate efficacy and toxicity of continuous infusion ifosfamide plus etoposide combination in elderly patients (older than 70 years) with intermediate or high grade non Hodgkin's lymphoma. Chemotherapy w
Autor:
Bertrand Coiffier, Y. Bastion, Gilles Salles, I. Moullet, Pascale Felman, Dominique Morel, Charles Dumontet
Publikováno v:
European Journal of Haematology. 54:127-129
Autor:
Y. Bastion, Pierre Coeur, Sophie Gazzo, Françoise Berger, Pascale Felman, Evelyne Callet-Bauchu, Jacqueline Pagès, Ruth Rimokh
Publikováno v:
Cancer Genetics and Cytogenetics. 98:16-19
Recent evidence has shown that rare cases of aggressive non-Hodgkin lymphomas (NHL) derive from cells belonging to the natural killer (NK) lymphocyte lineage and a new clinico pathologic entity has been proposed. Though well documented in B- and T-ce
Autor:
Philippe Moreau, N Straetmans, I Tabah, Philippe Solal-Celigny, Corinne Haioun, Nicole Brousse, Pauline Brice, Eric Lepage, H. Tilly, Y. Bastion
Publikováno v:
Journal of Clinical Oncology. 15:1110-1117
PURPOSE To evaluate prospectively in patients with follicular lymphoma and a low tumor burden three therapeutic options: delay of any treatment until clinically meaningful progression, immediate treatment with an oral alkylating agent, or treatment w
Autor:
Nathalie Renard, Krzysztof Warzocha, Y. Bastion, Jacques Bienvenu, Charles Dumontet, E. M. Neidhardt-Berard, Gilles Salles, B. Coiffier
Publikováno v:
Journal of Clinical Oncology. 15:499-508
PURPOSE A prospective study was performed to assess plasma measurement of tumor necrosis factor (TNF), lymphotoxin alpha (LTalpha), and their soluble receptors (p55 and p75) for prognostic risk assignment in patients with malignant lymphomas. PATIENT
Autor:
André Bosly, Bertrand Coiffier, Gerald Marit, Antoine Yver, Christian Gisselbrecht, Hervé Tilly, Jean Pierre Marolleau, Felix Reyes, Corinne Haioun, Eric Deconinck, Brigitte Dupriez, Y. Bastion, Raoul Herbrecht, Eric Lepage, Farida Dabouz-Harrouche
Publikováno v:
Leukemia & Lymphoma. 25:289-300
The purpose of this study was to, assess the efficacy of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in the prevention of neutropenia and infection in patients receiving dose-intensive chemotherapy for non-Hodgk
Autor:
Jean-Pierre Marolleau, Felix Reyes, Pauline Brice, Anne Sonet, Daniel Espinouse, Y. Bastion, B. Coiffier, Christian Gisselbrecht, Corinne Haioun, Gilles Salles
Publikováno v:
Europe PubMed Central
Intensive therapy, mainly with purged autologous bone marrow transplantation (ABMT), has been proposed in recent years as consolidation treatment in young patients with follicular lymphoma. Reported experience with transplantation of peripheral blood
Autor:
N. A. Bekassy, Göran Elinder, Y. Bastion, L. Wranne, W. A. Kamps, Pierre Bordigoni, Marianne Debré, M. Lanning, A. Makipernaa, Sarah E. Ball, Thierry Leblanc, Gil Tchernia
Publikováno v:
British Journal of Haematology. 91:313-318
Forty patients (nine adults aged 20-54; 31 children aged 1-17) with Diamond-Blackfan anaemia (DBA) were treated with recombinant human interleukin-3 (IL-3) in a European multicentre compassionate-need study. IL-3 was given as a daily subcutaneous inj
Autor:
Eric Archimbaud, Catherine Sebban, B. Christian, Qk. Bach, N. Gratecos, Y. Bastion, André Bosly, Xavier Thomas, R. Leblay, Bernadette Corront, Denis Fiere, C. Danaïla, Philippe Dufour
Publikováno v:
Annals of Hematology. 70:65-69
Sequential chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone doses was administered to 57 adult patients with acute lymphoblastic leukemia (ALL). Complete remission (CR) was achieved in 51 (89%, 95% confidence intervals, [
Autor:
A Delannoy, H. Tilly, Y. Bastion, P. Morel, Kamal Bouabdallah, Corinne Haioun, C. Nouvel, Brigitte Dupriez, E Baumelou, Raoul Herbrecht
Publikováno v:
British Journal of Cancer. 70:154-159
In order to describe renal involvement in aggressive non-Hodgkin's lymphomas (NHLs) and its prognostic significance, we reviewed the outcome of 48 patients with renal involvement treated with the LNH-84 or LNH-87 regimen. Histology was diffuse large